Fetal brain development: The role of maternal nutrition, exposures and behaviors

Journal of Pediatric Neurology

Volumn 4, Issue 1, 2006, Pages 1-9

  Massaro, An N ^a,b   Rothbaum, Rebecca ^a   Aly, Hany ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

Arachidonic acid; Copper; Docosahexaenoic acid; exercise; Folate; Iodine; Iron; music; Toxin; Vitamin B6

Indexed keywords

ARACHIDONIC ACID; COPPER; DOCOSAHEXAENOIC ACID; FOLIC ACID; IODINE; IRON; LEAD; MERCURY; PROTEIN; PSYCHOTROPIC AGENT; PYRIDOXINE; SELENIUM; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID; ZINC;

ALCOHOLISM; BRAIN ATROPHY; BRAIN DEVELOPMENT; BRAIN DYSFUNCTION; CHILD NEGLECT; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE DEFECT; CONGENITAL HYPOTHYROIDISM; COPPER DEFICIENCY; CYANOCOBALAMIN DEFICIENCY; DIET SUPPLEMENTATION; DRUG ABUSE; ECG ABNORMALITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EVOKED AUDITORY RESPONSE; EXERCISE; FETAL ALCOHOL SYNDROME; FETUS DEVELOPMENT; FOLIC ACID DEFICIENCY; HUMAN; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; IODINE DEFICIENCY; IRON DEFICIENCY; LANGUAGE DISABILITY; MATERNAL BEHAVIOR; MATERNAL NUTRITION; MEDLINE; MENTAL DEFICIENCY; MORBIDITY; NEURAL TUBE DEFECT; NEUROTOXICITY; NEWBORN INFECTION; NONHUMAN; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; PERINATAL ASPHYXIA; PERINATAL PERIOD; PREMATURITY; PRENATAL DRUG EXPOSURE; PRENATAL EXPOSURE; PYRIDOXINE DEFICIENCY; RADIATION DOSE; RADIATION EXPOSURE; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELENIUM DEFICIENCY; SENSORY STIMULATION; SMOKING; SOCIAL STATUS; SYSTEMATIC REVIEW; TERATOGENESIS; TOBACCO DEPENDENCE; VEGETARIAN DIET; VITAMIN SUPPLEMENTATION; ZINC DEFICIENCY;

EID: 33845546416     PISSN: 13042580     EISSN: 18759041     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. J. Dobbing and J. Sands, Quantitative growth and development of human brain, Arch Dis Child 48 (1973), 757-767.
2. J.J. Volpe, Neurology of the Newborn, (3rd ed.), Philadelphia, WB Saunders, 1995.
3. M. Thame, R.J. Wilks, N. McFarlane-Anderson, F.I. Bennett and T.E. Forrester, Relationship between maternal nutritional status and infant's weight and body proportions at birth, Eur J Clin Nutr 51 (1997), 134-138.
4. B. Luke, C. Dickinson and R.H. Petrie, Intrauterine growth: Correlations of maternal nutritional status and rate of gestational weight gain, Eur J Obstet Gynecol Reprod Biol 12 (1981), 113-121.
5. R. Morley and A. Lucas, Nutrition and cognitive development, Br Med Bull 53 (1997), 123-134.
6. R. Lingas, F. Dean and S.G. Matthews, Maternal nutrient restriction (48 h) modifies brain corticosteroid receptor expression and endocrine function in the fetal guinea pig, Brain Res 846 (1999), 236-242.
7. Food and Nutrition Board, National Research Council: Recommended daily allowances, (10th ed.), Washington DC: National Academy Press; 1989.
8. J.L. Mills, J.M. Scott, P.N. Kirke et al., Homocysteine and neural tube defects, J Nutr 126 (1996), 756S-760S.
9. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study, Lancet 338 (1991), 131-137.
10. T.O. Scholl, M.L. Hediger, J.I. Schall, C.S. Khoo and R.L. Fischer, Dietary and serum folate: Their influence on the outcome of pregnancy, Am J Clin Nutr 63 (1996), 520-525.
11. E. Hamaoui and M. Hamaoui, Nutritional assessment and support during pregnancy, Gastroenterol Clin North Am 32 (2003), 59-121.
12. S.A. Rasmussen, P.M. Fernhoff and K.S. Scanlon, Vitamin B12 deficiency in children and adolescents, J Pediatr 138 (2001), 10-17.
13. U. von Schenck, C. Bender-Gotze and B. Koletzko, Persistence of neurological damage induced by dietary vitamin B12 deficiency in infancy, Arch Dis Child 77 (1997), 137-139.
14. S.M. Graham, O.M. Arvela and G.A. Wise, Long-term neurologic consequences of nutritional vitamin B12 deficiency in infants, J Pediatr 121 (1992), 710-714.
15. P.T. Monagle and G.P. Tauro, Infantile megaloblastosis secondary to maternal vitamin B12 deficiency, Clin Lab Haematol 19 (1997), 23-25.
16. C. Koebnick, I. Hoffmann, P.C. Dagnelie et al., Long-term ovo-lacto vegetarian diet impairs vitamin B12 status in pregnant women, J Nutr 134 (2004), 3319-3326.
17. T.R. Guilarte, Vitamin B6 and cognitive development: Recent research findings from human and animal studies, Nutr Rev 51 (1993), 193-198.
18. A. Kirksey, D.M. Morre and A.Z. Wasynczuk, Neuronal development in vitamin B6 deficiency, Ann N Y Acad Sci 585 (1990), 202-218.
19. S. Jameson, Zinc status in pregnancy: The effect of zinc therapy on perinatal mortality, prematurity, and placental ablation, Ann N Y Acad Sci 678 (1993), 178-192.
20. T.O. Scholl, M.L. Hediger, J.I. Schall, R.L. Fischer and C.S. Khoo, Low zinc intake during pregnancy: Its association with preterm and very preterm delivery, Am J Epidemiol 137 (1993), 1115-1124.
21. S. Bhatnagar and S. Taneja, Zinc and cognitive development, Br J Nutr 85(Suppl 2) (2001), S139-S145.
22. J.D. Hamadani, G.J. Fuchs, S.J. Osendarp, S.N. Huda and S.M. Grantham-McGregor, Zinc supplementation during pregnancy and effects on mental development and behaviour of infants: A follow-up study, Lancet 360 (2002), 290-294.
23. J.R. Prohaska and R.G. Hoffman, Auditory startle response is diminished in rats after recovery from perinatal copper deficiency, J Nutr 126 (1996), 618-627.
24. J.R. Prohaska, Long-term functional consequences of malnutrition during brain development: Copper, Nutrition 16 (2000), 502-504.
25. L.H. Allen, Iron-deficiency anemia increases risk of preterm delivery, Nutr Rev 51 (1993), 49-52.
26. M.B. Youdim, Nutrient deprivation and brain function: Iron, Nutrition 16 (2000), 504-508.
27. R. Rao, M. de Ungria, D. Sullivan et al., Perinatal brain iron deficiency increases the vulnerability of rat hippocampus to hypoxic ischemic insult, J Nutr 129 (1999), 199-206.
28. K.N. Agarwal, Iron and the brain: Neurotransmitter receptors and magnetic resonance spectroscopy, Br J Nutr 85(Suppl 2) (2001), S147-S150.
29. H. Guvenc, F. Karatas, M. Guvenc, S. Kunc, A.D. Aygun and S. Bektas, Low levels of selenium in mothers and their newborns in pregnancies with a neural tube defect, Pediatrics 95 (1995), 879-882.
30. N.D. McGlashan, S.J. Cook, W. Melrose, P.L. Martin, E. Chelkowska and R.J. von Witt, Maternal selenium levels and sudden infant death syndrome (SIDS), Aust N Z J Med 26 (1996), 677-682.
31. J.T. Dunn, Iodine supplementation and the prevention of cretinism, Ann N Y Acad Sci 678 (1993), 158-168.
32. B.S. Hetzel and M.T. Mano, A review of experimental studies of iodine deficiency during fetal development, J Nutr 119 (1989), 145-151.
33. F. Delange, The role of iodine in brain development, Proc Nutr Soc 59 (2000), 75-79.
34. K.J. Connolly, P.O. Pharoah and B.S. Hetzel, Fetal iodine deficiency and motor performance during childhood, Lancet 2 (1979), 1149-1151.
35. B.S. Hetzel, Iodine and neuropsychological development, J Nutr 130 (2000), 493S-495S.
36. G.C. Burdge, R.L. Dunn, S.A. Wootton and A.A. Jackson, Effect of reduced dietary protein intake on hepatic and plasma essential fatty acid concentrations in the adult female rat: Effect of pregnancy and consequences for accumulation of arachidonic and docosahexaenoic acids in fetal liver and brain, Br J Nutr 88 (2002), 379-387.
37. P.S. Sastry, Lipids of nervous tissue: Composition and metabolism, Prog Lipid Res 24 (1985), 69-176.
38. E.E. Birch, D.G. Birch, D.R. Hoffman and R. Uauy, Dietary essential fatty acid supply and visual acuity development, Invest Ophthalmol Vis Sci 33 (1992), 3242-3253.
39. E. Yavin, S. Glozman and P. Green, Docosahexaenoic acid sources for the developing brain during intrauterine life, Nutr Health 15 (2001), 219-224.
40. S.M. Innis and S. de La Presa Owens, Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain, J Nutr 131 (2001), 118-122.
41. I.B. Helland, L. Smith, K. Saarem, O.D. Saugstad and C.A. Drevon, Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age, Pediatrics 111 (2003), e39-e44.
42. C. Jensen, R. Voight, A. Llorente et al., Effect of maternal docosahexaenoic acid DHA) supplementation on neuropsychological and visual status of former breast-fed infants at five years of age, Pediatr Res 55 (2004), 1021.
43. O.N. Hansen, A. Trillingsgaard, I. Beese, T. Lyngbye and A. Grandjean, A neuropsychological study of children with elevated dentine lead level: assessment of the effect of lead in different socio-economic groups, Neurotoxicol Teratol 11 (1989), 205-213.
44. G. Winneke, A. Brockhaus, U. Ewers, U. Kramer and M. Neuf, Results from the European multicenter study on lead neurotoxicity in children: implications for risk assessment, Neurotoxicol Teratol 12 (1990), 553-559.
45. R.A. Goyer, Lead toxicity: Current concerns, Environ Health Perspect 100 (1993), 177-187.
46. D.A. Cory-Slechta, Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity, Neurotoxicology 18 (1997), 673-688.
47. J. Rossouw, J. Offermeier and J.M. van Rooyen, Apparent central neurotransmitter receptor changes induced by low-level lead exposure during different developmental phases in the rat, Toxicol Appl Pharmacol 91 (1987), 132-139.
48. Z. Shao and J.B. Suszkiw, Ca2(+)-surrogate action of Pb2+ on acetylcholine release from rat brain synaptosomes, J Neurochem 56 (1991), 568-574.
49. M. Weitzman and D. Glotzer, Lead poisoning, Pediatr Rev 13 (1992), 461-468.
50. E.K. Silbergeld and T.E. Patrick, Environmental exposures, toxicologic mechanisms, and adverse pregnancy outcomes, Am J Obstet Gynecol 192 (2005), S11-S21.
51. T.M. Burbacher, P.M. Rodier and B. Weiss, Methylmercury developmental neurotoxicity: A comparison of effects in humans and animals, Neurotoxicol Teratol 12 (1990), 191-202.
52. K. Eto, Pathology of Minamata disease, Toxicol Pathol 25 (1997), 614-623.
53. P. Grandjean, E. Budtz-Jorgensen, R.F. White et al., Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years, Am J Epidemiol 150 (1999), 301-305.
54. U. Steuerwald, P. Weihe, P.J. Jorgensen et al., Maternal seafood diet, methylmercury exposure, and neonatal neurologic function, J Pediatr 136 (2000), 599-605.
55. L.C. Pimperl, Radiation as a nervous system toxin, Neurol Clin 23 (2005), 571-597.
56. B.P. Harrison and C.S. Crystal, Imaging modalities in obstetrics and gynecology, Emerg Med Clin North Am 21 (2003), 711-735.
57. W. Luck, H. Nau, R. Hansen and R. Steldinger, Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking others, Dev Pharmacol Ther 8 (1985), 384-395.
58. T.A. Slotkin, Developmental cholinotoxicants: Nicotine and chlorpyrifos, Environ Health Perspect 107 (1999), 71-80.
59. P.A. Fried, B. Watkinson and R. Gray, Growth from birth to early adolescence in offspring prenatally exposed to cigarettes and marijuana, Neurotoxicol Teratol 21 (1999), 513-525.
60. S.L. Leech, G.A. Richardson, L. Goldschmidt and N.L. Day, Prenatal substance exposure: Effects on attention and impulsivity of 6-year-olds, Neurotoxicol Teratol 21 (1999), 109-118.
61. Y. Tizabi, E.J. Popke, M.A. Rahman, S.M. Nespor and N.E. Grunberg, Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors, Pharmacol Biochem Behav 58 (1997), 141-146.
62. J.L. Gingras and K.J. O'Donnell, State control in the substance-exposed fetus. I. The fetal neurobehavioral profile: An assessment of fetal state, arousal, and regulation competency, Ann N Y Acad Sci 846 (1998), 262-276.
63. C. Obel, T.B. Henriksen, M. Hedegaard, N.J. Secher and J. Ostergaard, Smoking during pregnancy and babbling abilities of the 8-month-old infant, Paediatr Perinat Epidemiol 12 (1998), 37-48.
64. J.R. DiFranza, C.A. Aligne and M. Weitzman, Prenatal and postnatal environmental tobacco smoke exposure and children's health, Pediatrics 113 (2004), 1007-1015.
65. K.L. Jones, D.W. Smith, C.N. Ulleland and P. Streissguth, Pattern of malformation in offspring of chronic alcoholic mothers, Lancet 1 (1973), 1267-1271.
66. M.E. Charness, Molecular mechanisms of ethanol intoxication, tolerance and physical dependence, in: Medical Diagnosis and Treatment of Alcoholism, J.H. Mendelson and N.K. Mello, eds, NewYork, McGraw-Hill, 1992, pp. 155-200.
67. H.H. Samson, G.A. Tolliver, M. Haraguchi and C.W. Hodge, Alcohol self-administration: Role of mesolimbic dopamine, Ann N Y Acad Sci 654 (1992), 242-253.
68. D.M. Lovinger and G. White, Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons, Mol Pharmacol 40 (1991), 263-270.
69. A.P. Streissguth, H.M. Barr, J. Kogan et al., Understanding the Occurrence of Secondary Disabilities in Clients with Fetal Alcohol Syndrome and Fetal Alcohol Effects, Seattle: University of Washington Press, 1996.
70. A.S. Wilkins, J.J. Marota, E. Tabit and B.E. Kosofsky, Transplacental cocaine exposure. 3: Mechanisms underlying altered brain development, Neurotoxicol Teratol 20 (1998), 239-249.
71. M. Mirochnick, D.A. Frank, H. Cabral, A. Turner and B. Zuckerman, Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth, J Pediatr 126 (1995), 636-638.
72. B. Zuckerman, D.A. Frank, R. Hingson et al., Effects of maternal marijuana and cocaine use on fetal growth, N Engl J Med 320 (1989), 762-768.
73. E.Z. Tronick, D.A. Frank, H. Cabral, M. Mirochnick and B. Zuckerman, Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance, Pediatrics 98 (1996), 76-83.
74. V. Delaney-Black, C. Covington, E. Ostrea Jr. et al., Prenatal cocaine and neonatal outcome: Evaluation of dose-response relationship, Pediatrics 98 (1996), 735-740.
75. C.A. Chiriboga, M. Vibbert, R. Malouf et al., Neurological correlates of fetal cocaine exposure: Transient hypertonia of infancy and early childhood, Pediatrics 96 (1995), 1070-1077.
76. I. Nulman, J. Rovet, D. Altmann, C. Bradley, T. Einarson and G. Koren, Neurodevelopment of adopted children exposed in utero to cocaine, CMAJ 151 (1994), 1591-1597.
77. T.F. Oberlander, R. Eckstein Grunau, C. Fitzgerald et al., Prolonged prenatal psychotropic medication exposure alters neonatal acute pain response, Pediatr Res 51 (2002), 443-453.
78. E. Robert and P. Guibaud, Maternal valproic acid and congenital neural tube defects, Lancet 2 (1982), 937.
79. E.J. Lammer, D.T. Chen, R.M. Hoar et al., Retinoic acid embryopathy, N Engl J Med 313 (1985), 837-841.
80. D. Mittelman, Amblyopia, Pediatr Clin North Am 50 (2003), 189-196.
81. K.J. Gerhardt and R.M. Abrams, Fetal exposures to sound and vibroacoustic stimulation, J Perinatol 20 (2000), S21-S30.
82. F.H. Rauscher, K.D. Robinson and J.J. Jens, Improved maze learning through early music exposure in rats, Neurol Res 20 (1998), 427-432.
83. P. Parnpiansil, N. Jutapakdeegul, T. Chentanez and N. Kotchabhakdi, Exercise during pregnancy increases hippocampal brain-derived neurotrophic factor mRNA expression and spatial learning in neonatal rat pup, Neurosci Lett 352 (2003), 45-48.
84. J.F. Clapp, 3rd., Morphometric and neurodevelopmental outcome at age five years of the offspring of women who continued to exercise regularly throughout pregnancy, J Pediatr 129 (1996), 856-863.